{"id":"https://openalex.org/W2602809045","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","title":"Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies","display_name":"Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2602809045","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","mag":"2602809045"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.4073","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083781305","display_name":"Bruce J. Giantonio","orcid":"https://orcid.org/0000-0002-2475-1939","observed_orcids":["https://orcid.org/0000-0002-2475-1939"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"B. J. Giantonio","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053128814","display_name":"Neal J. Meropol","orcid":"https://orcid.org/0000-0001-6353-7364","observed_orcids":["https://orcid.org/0000-0001-6353-7364"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"N. J. Meropol","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069129452","display_name":"Paul J. Catalano","orcid":"https://orcid.org/0000-0002-1105-8852","observed_orcids":["https://orcid.org/0000-0002-1105-8852"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"P. J. Catalano","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023756286","display_name":"Victor Ng","orcid":"https://orcid.org/0000-0002-7428-0688","observed_orcids":["https://orcid.org/0000-0002-7428-0688"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"V. Ng","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109167613","display_name":"Rebecca Oliver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"R. Oliver","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037079479","display_name":"Florin Sirz\u00e9n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"F. Sirzen","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110152289","display_name":"SC Leonard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"S. Leonard","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053128035","display_name":"Jim Cassidy","orcid":"https://orcid.org/0000-0003-3917-561X","observed_orcids":["https://orcid.org/0000-0003-3917-561X"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"J. Cassidy","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029706633","display_name":"Al B. Benson","orcid":"https://orcid.org/0000-0001-5485-7227","observed_orcids":["https://orcid.org/0000-0001-5485-7227"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"A. B. Benson","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Genentech BioOncology, South San Francisco, CA; F. Hoffmann-La Roche, Basel, Switzerland; Memorial Sloan-Kettering Cancer Center, New York, NY; Glasgow University, Glasgow, United Kingdom; Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I118019719","https://openalex.org/I1289437631","https://openalex.org/I1334819555","https://openalex.org/I4210117453","https://openalex.org/I7882870","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"4073","last_page":"4073"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9150000214576721},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.9750000238418579},{"id":"https://openalex.org/keywords/xelox","display_name":"XELOX","score":0.9789999723434448},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9110000133514404},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.8820000290870667},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9879999756813049},{"id":"https://openalex.org/keywords/primary-endpoint-selection","display_name":"primary endpoint selection","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.9407929182052612},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.9067472219467163},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8734747767448425},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8456180095672607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7107935547828674},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6442115306854248},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6131781935691833},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.5729202032089233},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5669469237327576},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.497562438249588},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.49417880177497864},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.4415246248245239},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41610297560691833},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41492316126823425},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35133522748947144},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2662399113178253},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2051333487033844},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.4073","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.4073","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2921123888","https://openalex.org/W2084464231","https://openalex.org/W3009722442","https://openalex.org/W1967687854","https://openalex.org/W2589495284","https://openalex.org/W2999983310","https://openalex.org/W2588412679","https://openalex.org/W2907871591","https://openalex.org/W2978027279","https://openalex.org/W3011015366"],"abstract_inverted_index":{"4073":[0],"Background:":[1],"In":[2,129],"trials":[3,250],"of":[4,17,43,71,87,139,168,200,210,219,224,231],"BV":[5,84,103,124,165],"with":[6,64,98,116,196],"FOLFOX":[7,101,121],"(fluorouracil,":[8],"leucovorin,":[9],"oxaliplatin)":[10],"for":[11,47,82,153,163,173,177,206,228],"mCRC,":[12],"variability":[13],"in":[14,24,35,41,57,59,189,236,247],"the":[15,60,83,140,164,169,186,217,222,229],"magnitude":[16,223],"PFS":[18,81,143,154,162,225,256],"improvement":[19],"has":[20],"been":[21],"reported":[22],"[HR=0.61":[23],"E3200":[25,93],"vs":[26,120],"HR=":[27],"0.83":[28],"(FOLFOX":[29],"or":[30,127],"CAPOX":[31,119],"(capecitabine":[32],"and":[33,75,122,149,192,221,243],"oxaliplatin))":[34],"NO16966].":[36],"We":[37,66],"propose":[38],"that":[39,111],"differences":[40,58,184],"rates":[42],"treatment":[44],"discontinuation":[45],"(D/C)":[46],"adverse":[48],"events":[49],"(AE)":[50],"between":[51,185],"these":[52,237],"studies":[53,188],"may":[54],"have":[55,214],"resulted":[56],"observed":[61,227],"benefits":[62],"associated":[63],"BV.":[65],"explored":[67],"Tx":[68,76,133,190,193,205,212,241,245],"duration":[69,191,242],"(proportion":[70],"patients":[72,97,115,201],"on":[73,202],"Tx)":[74],"D/C":[77,194,246],"data":[78,181],"at":[79],"median":[80],"containing":[85,166],"arms":[86],"each":[88],"study.":[89],"Methods:":[90],"ECOG":[91],"study":[92,132,211],"randomized":[94,112],"previously":[95,113],"treated":[96],"mCRC":[99,117],"to":[100,118,123,233,240,269],"\u00b1":[102],"(10":[104],"mg/kg).":[105],"NO16966":[106,178,203],"employed":[107],"a":[108,197,258],"2x2":[109],"design":[110],"untreated":[114],"(5":[125],"mg/kg)":[126],"placebo.":[128],"both":[130,216],"trials,":[131],"was":[134,144],"defined":[135],"as":[136,257],"any":[137,207],"component":[138],"prescribed":[141],"regimen.":[142],"estimated":[145,156],"from":[146],"Kaplan-Meier":[147],"curves,":[148],"hazard":[150],"ratios":[151],"(HR)":[152],"were":[155],"by":[157],"Cox":[158],"regression.":[159],"Results:":[160],"Median":[161],"arm":[167],"study:":[170],"30":[171],"weeks":[172,176],"E3200;":[174],"42":[175],"Conclusion:":[179],"These":[180],"suggest":[182],"possible":[183],"two":[187],"patterns":[195],"greater":[198],"proportion":[199],"discontinuing":[204],"AE.":[208],"Duration":[209],"might":[213],"affected":[215],"incidence":[218],"AEs":[220],"benefit":[226],"addition":[230],"bevacizumab":[232],"oxaliplatin-based":[234],"chemotherapy":[235],"studies.":[238],"Attention":[239],"Non-PD":[244],"future":[248],"clinical":[249],"will":[251],"be":[252],"important":[253],"when":[254],"considering":[255],"primary":[259],"efficacy":[260],"endpoint.":[261],"[Table:":[262],"see":[263],"text]":[264],"No":[265],"significant":[266],"financial":[267],"relationships":[268],"disclose.":[270]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2017-04-07T00:00:00"}